Found: 15
Select item for more details and to access through your institution.
Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64<sup>+</sup> cells.
- Published in:
- Scientific Reports, 2015, p. 18308, doi. 10.1038/srep18308
- By:
- Publication type:
- Article
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11100-0
- By:
- Publication type:
- Article
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0258041
- By:
- Publication type:
- Article
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253178
- By:
- Publication type:
- Article
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS‐COV‐2 Antibodies.
- Published in:
- ChemBioChem, 2023, v. 24, n. 15, p. 1, doi. 10.1002/cbic.202300103
- By:
- Publication type:
- Article
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202200008
- By:
- Publication type:
- Article
Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
- Published in:
- European Journal of Immunology, 2017, v. 47, n. 2, p. 385, doi. 10.1002/eji.201646583
- By:
- Publication type:
- Article
Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 3, p. 598, doi. 10.1002/eji.201141613
- By:
- Publication type:
- Article
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24347-7
- By:
- Publication type:
- Article
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
- Published in:
- Immunology, 2013, v. 140, n. 2, p. 211, doi. 10.1111/imm.12129
- By:
- Publication type:
- Article
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3116, doi. 10.3390/cancers13133116
- By:
- Publication type:
- Article
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.682492
- By:
- Publication type:
- Article